|
|
Name: |
StemPoint Capital LP |
City: |
NEW YORK |
State: |
NY |
Zip: |
10022 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
55 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
ROIV |
Roivant Sciences Ltd. |
1 |
- |
$11.03 |
$24,359,000 |
2,169,116 |
6.56% |
0 |
0 |
0.313 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
2 |
- |
$21.06 |
$23,652,000 |
1,094,494 |
6.37% |
0 |
0 |
1.426 |
N/A |
|
ACLX |
Arcellx, Inc. |
3 |
- |
$0.00 |
$17,405,000 |
313,604 |
4.69% |
0 |
0 |
0.64 |
N/A |
|
MRUS |
Merus Nv |
4 |
- |
$45.04 |
$13,800,000 |
501,806 |
3.72% |
0 |
0 |
1.176 |
N/A |
|
IMVT |
Immunovant Inc |
5 |
- |
$0.00 |
$13,566,000 |
322,015 |
3.66% |
0 |
0 |
0.37 |
N/A |
|
FOLD |
Amicus Therapeutics Inc |
6 |
- |
$10.61 |
$12,243,000 |
862,815 |
3.3% |
0 |
0 |
0.254 |
Biotechnology |
|
PTGX |
Protagonist Therapeutics, Inc |
7 |
- |
$25.15 |
$11,779,000 |
513,681 |
3.17% |
0 |
0 |
0.914 |
N/A |
|
IMTX |
Immatics N.V |
8 |
- |
$10.01 |
$10,743,000 |
1,020,214 |
2.89% |
0 |
0 |
1.622 |
N/A |
|
BBIO |
Bridgebio Pharma, Inc. |
9 |
- |
$24.88 |
$10,252,000 |
253,948 |
2.76% |
0 |
0 |
0.159 |
N/A |
|
CABA |
Cabaletta Bio, Inc. |
10 |
- |
$0.00 |
$10,231,000 |
450,706 |
2.76% |
0 |
0 |
1.742 |
N/A |
|
MLTX |
Multisys Language Solutions... |
11 |
- |
$0.00 |
$10,137,000 |
167,851 |
2.73% |
0 |
0 |
0.408 |
N/A |
|
MRK |
Merck & Co Inc |
12 |
- |
$131.20 |
$9,705,000 |
89,016 |
2.62% |
0 |
0 |
0.004 |
Drug Manufacturers - ... |
|
JNJ |
Johnson & Johnson |
13 |
- |
$146.14 |
$9,563,000 |
61,011 |
2.58% |
0 |
0 |
0.002 |
Drug Manufacturers - ... |
|
CRNX |
Crinetics Pharmaceuticals, ... |
14 |
- |
$42.12 |
$8,880,000 |
249,575 |
2.39% |
0 |
0 |
0.43 |
N/A |
|
LLY |
Eli Lilly & Co |
15 |
- |
$733.51 |
$8,783,000 |
15,067 |
2.37% |
0 |
0 |
0.002 |
Drug Manufacturers - ... |
|
VTGN |
Vistagen Therapeutics Inc |
16 |
- |
$4.75 |
$8,764,000 |
1,790,182 |
2.36% |
0 |
0 |
18.551 |
Biotechnology |
|
ARQT |
Arcutis Biotherapeutics, Inc. |
17 |
- |
$8.47 |
$8,380,000 |
2,594,536 |
2.26% |
0 |
0 |
3.454 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
18 |
- |
$0.60 |
$8,151,000 |
378,766 |
2.2% |
0 |
0 |
0.619 |
N/A |
|
IRON |
Disc Medicine, Inc |
19 |
- |
$27.55 |
$7,245,000 |
125,429 |
1.95% |
0 |
0 |
0.72 |
N/A |
|
LNTH |
Lantheus Holdings, Inc. |
20 |
- |
$65.56 |
$6,752,000 |
108,911 |
1.82% |
0 |
0 |
0.151 |
N/A |
|
LEGN |
Churchill Cap Corp Iii |
21 |
- |
$45.30 |
$6,297,000 |
104,650 |
1.7% |
0 |
0 |
0.081 |
N/A |
|
ATXS |
Astria Therapeutics, Inc |
22 |
- |
$9.00 |
$6,162,000 |
856,952 |
1.66% |
0 |
0 |
3.455 |
N/A |
|
INSM |
Insmed Inc |
23 |
- |
$24.80 |
$5,379,000 |
173,579 |
1.45% |
0 |
0 |
0.115 |
Biotechnology |
|
KALV |
Kalvista Pharmaceuticals Inc |
24 |
- |
$10.78 |
$5,184,000 |
423,174 |
1.4% |
0 |
0 |
1.253 |
N/A |
|
BHVN |
Biohaven Ltd. |
25 |
- |
$38.97 |
$4,766,000 |
111,354 |
1.28% |
0 |
0 |
0.163 |
N/A |
|
SAGE |
Sage Therapeutics, Inc. |
26 |
- |
$0.00 |
$4,731,000 |
218,319 |
1.27% |
0 |
0 |
0.375 |
N/A |
|
MDGL |
Madrigal Pharmaceuticals Inc |
27 |
- |
$193.33 |
$4,730,000 |
20,444 |
1.27% |
0 |
0 |
0.123 |
Diagnostic Substances |
|
SPY |
Standard & Poors Depository... |
28 |
- |
$508.26 |
$4,716,000 |
9,921 |
1.27% |
0 |
0 |
0 |
Closed - End Fund - E... |
|
ANIP |
ANI Pharmaceuticals Inc |
29 |
- |
$65.36 |
$4,708,000 |
85,382 |
1.27% |
0 |
0 |
0.418 |
Biotechnology |
|
ALPN |
Alpine Immune Sciences Inc |
30 |
- |
$64.56 |
$4,692,000 |
246,178 |
1.26% |
0 |
0 |
0.536 |
N/A |
|
ETNB |
89bio, Inc. |
31 |
- |
$8.26 |
$4,560,000 |
408,257 |
1.23% |
0 |
0 |
0.548 |
N/A |
|
SLRN |
Acelyrin, Inc. |
32 |
- |
$4.24 |
$4,382,000 |
587,373 |
1.18% |
0 |
0 |
0.604 |
N/A |
|
CBAY |
Cymabay Therapeutics, Inc. |
33 |
- |
$32.48 |
$4,305,000 |
182,258 |
1.16% |
0 |
0 |
0.192 |
N/A |
|
OLMA |
Olema Pharmaceuticals, Inc. |
34 |
- |
$0.00 |
$3,946,000 |
281,287 |
1.06% |
0 |
0 |
0.7 |
N/A |
|
LRMR |
Larimar Therapeutics Inc |
35 |
- |
$1.15 |
$3,563,000 |
783,172 |
0.96% |
0 |
0 |
1.961 |
N/A |
|
SCPH |
Scpharmaceuticals Inc. |
36 |
- |
$0.00 |
$3,556,000 |
567,211 |
0.96% |
0 |
0 |
1.737 |
N/A |
|
FATE |
Fate Therapeutics Inc |
37 |
- |
$3.80 |
$3,359,000 |
898,196 |
0.91% |
0 |
0 |
0.758 |
Biotechnology |
|
KNSA |
Kiniksa Pharmaceuticals, Ltd. |
38 |
- |
$17.88 |
$3,212,000 |
183,102 |
0.87% |
0 |
0 |
0.543 |
N/A |
|
APLT |
Applied Therapeutics Inc. |
39 |
- |
$0.00 |
$3,039,000 |
907,152 |
0.82% |
0 |
0 |
1.89 |
N/A |
|
NBIX |
Neurocrine Biosciences Inc |
40 |
- |
$135.99 |
$2,965,000 |
22,500 |
0.8% |
0 |
0 |
0.024 |
Biotechnology |
|
AUTL |
Autolus Therapeutics Plc |
41 |
- |
$4.00 |
$2,907,000 |
451,375 |
0.78% |
0 |
0 |
0.261 |
N/A |
|
ANNX |
Annexon, Inc. |
42 |
- |
$0.00 |
$2,756,000 |
607,100 |
0.74% |
0 |
0 |
0.705 |
N/A |
|
FULC |
Fulcrum Therapeutics, Inc. |
43 |
- |
$0.00 |
$2,542,000 |
376,573 |
0.68% |
0 |
0 |
0.597 |
N/A |
|
EYPT |
EyePoint Pharmaceuticals Inc |
44 |
- |
$0.44 |
$2,212,000 |
95,732 |
0.6% |
0 |
0 |
0.067 |
Biotechnology |
|
ACIU |
AC Immune SA |
45 |
- |
$2.35 |
$2,173,000 |
434,588 |
0.59% |
0 |
0 |
0.606 |
N/A |
|
CYTK |
Cytokinetics Inc |
46 |
- |
$65.34 |
$2,013,000 |
24,111 |
0.54% |
0 |
0 |
0.021 |
Biotechnology |
|
ARWR |
Arrowhead Pharmaceuticals Inc |
47 |
- |
$22.12 |
$1,807,000 |
59,038 |
0.49% |
0 |
0 |
0.058 |
Business Services |
|
AMAM |
Ambrx Biopharma Adr Represe... |
48 |
- |
$0.00 |
$1,796,000 |
126,101 |
0.48% |
0 |
0 |
0.14 |
N/A |
|
RAPT |
Rapt Therapeutics, Inc. |
49 |
- |
$8.10 |
$1,452,000 |
58,450 |
0.39% |
0 |
0 |
0.162 |
N/A |
|
OCUL |
Ocular Therapeutix, Inc |
50 |
- |
$0.00 |
$1,247,000 |
279,648 |
0.34% |
0 |
0 |
0.392 |
N/A |
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
51 |
- |
$0.00 |
$1,227,000 |
83,381 |
0.33% |
0 |
0 |
0.144 |
N/A |
|
STTK |
Shattuck Labs, Inc. |
52 |
- |
$0.00 |
$1,053,000 |
147,752 |
0.28% |
0 |
0 |
0.354 |
N/A |
|
ANAB |
Anaptysbio Inc |
53 |
- |
$21.00 |
$964,000 |
45,000 |
0.26% |
0 |
0 |
0.141 |
N/A |
|
TARS |
Tarsus Pharmaceuticals, Inc. |
54 |
- |
$0.00 |
$628,000 |
30,990 |
0.17% |
0 |
0 |
0.116 |
N/A |
|
CRGX |
Cargo Therapeutics, Inc. |
55 |
- |
$0.00 |
$622,000 |
26,875 |
0.17% |
0 |
0 |
0 |
N/A |
|